Xponance’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
32,342
+465
| +1% | +$25.6K | 0.01% | 563 |
|
|
2025
Q1 | $2.25M | Buy |
31,877
+202
| +0.6% | +$14.3K | 0.02% | 495 |
|
|
2024
Q4 | $2.08M | Buy |
31,675
+2,247
| +8% | +$148K | 0.02% | 512 |
|
|
2024
Q3 | $2.07M | Buy |
29,428
+121
| +0.4% | +$8.51K | 0.02% | 508 |
|
|
2024
Q2 | $2.41M | Buy |
29,307
+11,709
| +67% | +$964K | 0.02% | 456 |
|
|
2024
Q1 | $1.54M | Buy |
17,598
+8,632
| +96% | +$754K | 0.02% | 596 |
|
|
2023
Q4 | $865K | Sell |
8,966
-203
| -2% | -$19.6K | 0.01% | 721 |
|
|
2023
Q3 | $811K | Buy |
9,169
+226
| +3% | +$20K | 0.01% | 711 |
|
|
2023
Q2 | $775K | Buy |
8,943
+2,422
| +37% | +$210K | 0.01% | 743 |
|
|
2023
Q1 | $634K | Buy |
6,521
+18
| +0.3% | +$1.75K | 0.01% | 833 |
|
|
2022
Q4 | $673K | Buy |
6,503
+2,919
| +81% | +$302K | 0.01% | 786 |
|
|
2022
Q3 | $304K | Buy |
3,584
+112
| +3% | +$9.5K | 0.01% | 993 |
|
|
2022
Q2 | $288K | Buy |
+3,472
| New | +$288K | 0.01% | 1022 |
|
|
2021
Q3 | – | Sell |
-2,746
| Closed | -$229K | – | 1187 |
|
|
2021
Q2 | $229K | Sell |
2,746
-14,189
| -84% | -$1.18M | ﹤0.01% | 1138 |
|
|
2021
Q1 | $1.28M | Sell |
16,935
-146
| -0.9% | -$11K | 0.03% | 406 |
|
|
2020
Q4 | $1.5M | Buy |
17,081
+71
| +0.4% | +$6.23K | 0.03% | 371 |
|
|
2020
Q3 | $1.29M | Sell |
17,010
-21
| -0.1% | -$1.6K | 0.03% | 362 |
|
|
2020
Q2 | $2.1M | Buy |
+17,031
| New | +$2.1M | 0.05% | 260 |
|